Company Search:
Advanced Search
Sponsored Links
Adaptive Biotechnologies Corp Company Snapshot
Adaptive Biotechnologies Corp operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Adaptive Biotechnologies Corp with three other companies in this sector in the United States: bluebird bio Inc (2018 sales of $54.58 million of which 100% was Biological Products), Zymeworks Inc ($53.02 million of which 100% was Pharmaceutical), and Reata Pharmaceuticals Inc ($53.59 million of which 100% was Pharmaceutical).

Sales Analysis.
  Stock Performance Chart for Adaptive Biotechnologies Corp
  Stock Data: Recent Stock Performance:
  Current Price (1/24/2020): 30.55
(Figures in U.S. Dollars)
1 Week 8.3%   13 Weeks 4.4%  
4 Weeks 19.2%   52 Weeks n/a  
Adaptive Biotechnologies Corp Key Data:
  Ticker: ADPT Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 55,663,000
(Year Ending Jan 2019).
Employees: N/A
  Currency: U.S. Dollars Market Cap: 3,797,856,244
  Fiscal Yr Ends: December Shares Outstanding: 124,316,080
  Share Type: Ordinary Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.